NCT00242437已完成4 期
A Prospective, Multicenter Study to Evaluate Hemostatic Matrix With Bovine Thrombin in Achieving Hemostasis in Patients Undergoing Endoscopic Sinus Surgery
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 30
- 试验地点
- 6
- 主要终点
- Success in achieving hemostasis after product application
研究概览
简要总结
Evaluating clinical performance of Hemostatic Matrix with bovine thrombin in achieving hemostasis in patients undergoing endoscopic sinus surgery.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 主要目的
- Ect
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients who are 18 years or older.
- •Patients undergoing elective primary or re-do endoscopic sinus surgery for chronic sinusitis with bleeding surface requiring an adjunct to achieve hemostasis.
- •Patients must be willing and capable of cooperating to the extent and degree required by the protocol and sign the IRB approved Informed Consent Form prior to any participation in the study.
排除标准
- •Patients with bleeding diathesis, pathologic coagulopathy, systemic disorders, inflammatory conditions (other than chronic sinusitis or nasal polyposis) or autoimmune, immunodeficiency diseases or any other disorder that may interfere with hemostasis.
- •Patients with severe (brisk or forceful) bleeding site(s).
- •Patients undergoing urgent or emergency endoscopic sinus surgery.
- •Patients with bronchial asthma who have aspirin intolerance.
- •Patients with diffuse polyposis that would require chronic oral steroids or patients on chemotherapeutic agents that might delay healing (short term pulse steroid therapy and topical steroids are acceptable).
- •Patients who have used anticoagulant, antiplatelet or nonsteroidal anti-inflammatory analgesic (NSAID) within 7 days prior to surgery.
- •Patients who are morbidly obese (Body Mass Index > 35).
- •Patients with acute local infection at the operative side.
- •Patients who are current alcohol and/or drug abusers.
- •Patients with neoplasm, craniofacial abnormalities (e.g. cleft palate), or sleep apnea using nasal CPAP, or patients that may require a Lothrop procedure.
- •Female patients who are pregnant or nursing.
- •Patients who have uncontrolled diabetes mellitus (blood glucose levels >400 mg/dl) as determined by the Investigator based on medical history.
- •Patients who have participated in another investigational drug or device research within 30 days of enrollment.
- •Patients with known antibodies to bovine thrombin preparations, sensitivities or religious prohibitions to porcine gelatin or bovine components.
结局指标
主要结局
Success in achieving hemostasis after product application
次要结局
- Post operative healing
- Patient Satisfaction
- Time to hemostasis
研究者
研究点 (6)
Loading locations...
相似试验
进行中（未招募）
不适用
Random Evaluation of Patients Who Have Had Laparoscopic Partial NephrectomyKidney CancerNCT04120805University of Chicago178
撤回
不适用
Evaluation of Hemostatic Agents in Robotic-assisted Laparoscopic Partial NephrectomyRobotic-Assisted Laparoscopic Partial NephrectomyHemostatic AgentsRenal Malignant TumorNCT03528057Northwestern University
终止
不适用
Sepsis Assessment in Belgian Emergency RoomsShock, SepticSevere SepsisSepsisNCT02424721Axis Shield Diagnostics Ltd100
已完成
不适用
Clinical Evaluation of Hemospray in Hemostasis of Active Variceal BleedingVariceal HemorrhageNCT01783899Theodor Bilharz Research Institute30
已完成
不适用
Comparison of the Hemostatic Patch to Fibrin Sealant (TachoSil®) in Subjects Undergoing Hepatic SurgeryLiver DiseaseNCT01324349Medtronic - MITG50